MMI developed imaging sequences and assessment panels which are necessary to evaluate treatment outcomes including extent of lesion repair, bone-implant integration and overall device integrity.
The prospective, randomized study will be conducted in Taiwan to assess a cartilage repair treatment.
The biphasic implant is a two-phase scaffold which is designed to promote integration with subchondral bone and regeneration of hyaline-like cartilage.
During the study, MMI will provide comprehensive analysis and management of MR images.
Exactech clinical affairs director Matt Christensen said: "MMI is a valuable resource for clinical input on study design, and their commitment to customer services is impressive."
